Russell W. Budd Named to NCCN Foundation Board
NCCN announces the appointment of Russell W. Budd, president and managing shareholder of Baron & Budd, P.C., to the NCCN Foundation Board of Directors, the philanthropic affiliate of NCCN chaired by ABC news veteran, Sam Donaldson.
FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) welcomes Russell W. Budd, president and managing shareholder of Baron & Budd, P.C., as the newest member to the Board of the NCCN Foundation, the philanthropic affiliate of NCCN. The NCCN Foundation seeks support for programs to benefit patients with cancer as well as clinical researchers.
Mr. Budd is an exceptional addition to the NCCN Foundation Board, said Patricia J. Goldsmith, Executive Vice President and COO, NCCN. His esteemed reputation and ongoing commitment to patients with cancer and their families complement the mission of the NCCN Foundation to provide resources to improve the lives of patients with cancer. We are honored that he is willing to add his expertise to our current board, and we look forward to working with him on a number of initiatives.
Mr. Budd has been a shareholder of Baron & Budd since 1985 and president and managing shareholder since 2002. Over the last decade, Mr. Budd has played a significant role in protecting the rights of people injured by exposure to asbestos. Although the practice has expanded its scope to include cases as diverse as asbestos exposure, water contamination, Gulf Oil spill damages, unsafe pharmaceuticals, securities fraud and commercial litigation, Mr. Budd remains dedicated to protecting the rights of people who suffer from cancers like mesothelioma and lung cancer, which are often attributable to environmental toxins.
Under Mr. Budd`s direction, the firm has given generously to a number of asbestos awareness advocacy organizations as well as providing a cornerstone donation to the International Pleural Mesothelioma Program at Brigham & Women`s Hospital to research curative mesothelioma.
Given the complexity of today`s cancer care and new research emerging in the field, this board has the tremendous opportunity to educate people with cancer, such as mesothelioma, about their treatment options, said Mr. Budd. I am honored that the NCCN Foundation has made the visionary step of inviting an attorney to serve on their board and hopeful that together we can address the many needs of cancer patients.
Mr. Budd`s philanthropic endeavors continue outside of the firm as he and his wife are very involved in the community and are passionate supporters of Habitat for Humanity in the Dallas area. A father of two, he is active in his church and in his children`s many activities.
The NCCN Foundation was created to advance the NCCN mission of improving the quality and effectiveness of care provided to patients with cancer, while providing additional information and resources for informed decision-making. One of the primary initiatives of the NCCN Foundation is to gain support for the distribution of the NCCN Guidelines for Patients™. The NCCN Guidelines for Patients™ are translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) into patient-friendly language outlining appropriate treatments.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 26 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit NCCN.org.
The NCCN Member Institutions are:
- Fred & Pamela Buffett Cancer Center
- Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
- City of Hope Comprehensive Cancer Center
- Dana-Farber/Brigham and Women's Cancer Center
Massachusetts General Hospital Cancer Center
- Duke Cancer Institute
- Fox Chase Cancer Center
- Huntsman Cancer Institute at the University of Utah
- Fred Hutchinson Cancer Research Center / Seattle Cancer Care Alliance
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- Mayo Clinic Cancer Center
- Memorial Sloan Kettering Cancer Center
- Moffitt Cancer Center
- The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
- Roswell Park Cancer Institute
- Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
- St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
- Stanford Cancer Institute
- University of Alabama at Birmingham Comprehensive Cancer Center
- UC San Diego Moores Cancer Center
- UCSF Helen Diller Family Comprehensive Cancer Center
- University of Colorado Cancer Center
- University of Michigan Comprehensive Cancer Center
- The University of Texas MD Anderson Cancer Center
- Vanderbilt-Ingram Cancer Center
- Yale Cancer Center/Smilow Cancer Hospital